Specialty Pharmacy

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

The Centers for Medicare & Medicaid Services seeks to improve accuracy of data reported from direct and indirect remuneration fees.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

HIV-positive individuals are twice as likely to die of smoking than the disease.

Immune checkpoint inhibitors have revolutioned cancer treatment, but not all patients respond to immunotherapy.

Biosimilar programs seeks to increase accessibility to expensive medications.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Kevin Mange, MD, MSCE, head of North America Medical Immunology at Sanofi, provides a comprehensive overview of the considerations in the treatment of rheumatoid arthritis, which carries comorbidities that affect multiple organ systems.

The IL-17 inhibitor reduced the number of tender and swollen joints in at least 20% of patients with PsA.

Immunotherapies have improved survival in cancer patients.

While incidences of metastatic breast cancer are increasing, so is survival.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Isentress HD is a once daily treatment for HIV-1 that helps patients achieve viral suppression.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Tocilizumab (Actemra) is the first drug approved to treat giant cell arteritis.

Leader and follower cells depend on each other for survival and invasion.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

Surgeries that address colorectal cancer, ulcerative colitis, Crohn's disease, mechanical bowel obstruction and recurrent diverticulitis are often a necessity.

A how-to guide for pharmacy school students interested in pursuing a career in specialty pharmacy.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.